{"symbol":"ABT","fiscalQuarter":"Q1-2023","reportDate":"2023-04-19","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q1-2023","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Up 7.82%","keyNumbers":[{"metric":"EPS","actual":"$1.03","expected":"N/A","surprise":"+5.32%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported earnings that exceeded expectations on EPS, which contributed to a positive stock reaction, with shares rising by 7.82%. The lack of revenue data and management commentary leaves some uncertainty about the overall performance and future outlook. Investors may be encouraged by the EPS beat but will likely await further details in future reports.","metaDescription":"Abbott Laboratories (ABT) Q1 2023 earnings: EPS beat by 5.32%. Stock up 7.82%. Full breakdown."}}